Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Depreciation & Amortization (CF) (2022 - 2025)

Praxis Precision Medicines has reported Depreciation & Amortization (CF) over the past 4 years, most recently at -$12000.0 for Q4 2025.

  • Quarterly results put Depreciation & Amortization (CF) at -$12000.0 for Q4 2025, down 113.48% from a year ago — trailing twelve months through Dec 2025 was $100000.0 (down 75.0% YoY), and the annual figure for FY2025 was $100000.0, down 75.0%.
  • Depreciation & Amortization (CF) for Q4 2025 was -$12000.0 at Praxis Precision Medicines, down from $19000.0 in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for PRAX hit a ceiling of $119000.0 in Q2 2022 and a floor of -$12000.0 in Q4 2025.
  • Median Depreciation & Amortization (CF) over the past 4 years was $97500.0 (2022), compared with a mean of $82437.5.
  • Biggest five-year swings in Depreciation & Amortization (CF): rose 13.98% in 2023 and later tumbled 113.48% in 2025.
  • Praxis Precision Medicines' Depreciation & Amortization (CF) stood at $105000.0 in 2022, then decreased by 24.76% to $79000.0 in 2023, then rose by 12.66% to $89000.0 in 2024, then plummeted by 113.48% to -$12000.0 in 2025.
  • The last three reported values for Depreciation & Amortization (CF) were -$12000.0 (Q4 2025), $19000.0 (Q3 2025), and $46000.0 (Q2 2025) per Business Quant data.